From: Fauci, Anthony (NIH/NIAID) [E]

 

Sent: Thu, 6 Feb 2020 17:36:11 +0000
To:

Ce: 0) ©
Subject: RE: nCoV: Heads-up

Thanks, Jim.

Anthony S. Fauci, MD

Director

National Institute of Allergy and infectious Diseases
Building 31, Room 7A-03

31 Center Drive, MSC 2520

National Institutes of Health

Bethesda, MD 20892-2520

Phone:[ OO]
FAX: (301) 496-4409
E-mailf eee Lane.

The information in this e-mail and any of its attachments is confidential and may contain sensitive
information. It should not be used by anyone who is not the original intended recipient. If you
have received this e-mail in error please inform the sender and delete it from your mailbox or any
other storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall not
accept liability for any statements made that are the sender's own and not expressly made on
behalf of the NIAID by one of its representatives.

  

 

From 0) (6)
Sent: Thursday, February 6, 2020 10:33 AM

To: Fauci, Anthony (NIH/NIAID) (E]) OO)
1

Ce:
Subject: nCoV: Heads-up

Tony: As per below, we wanted to give you a heads up that (FY
a

CC. We will keep you updated. Best. John and Jim

French drugmaker Sanofi working on coronavirus initiative

CHINA-HEALTH/SANOFI (PIX):French drugmaker Sanofi working on _ coronavirus
initiative

 

PARIS, Feb 6 (Reuters) - French drugmaker Sanofi will announce a new coronavirus initiative
within the next two weeks, its chief executive said on Thursday, adding that it wants to present
something concrete and not add to "fantasies".

At least a dozen drugmakers are working on vaccines or antivirals to help those infected with the
fast-spreading virus that has killed more than 500 people in China. but several have warned that
development of treatments will take time.

NIH-002105
